Effect of ramipril on the incidence of diabetes.

Effect of ramipril on the incidence of diabetes.

BACKGROUND: Previous studies have suggested that blockade of the renin-angiotensin system may prevent diabetes in people with cardiovascular disease or hypertension. METHODS: In a double-blind, randomized clinical trial with a 2-by-2 factorial design, we randomly assigned 5269 participants without...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Bosch, J, Yusuf, S, Gerstein, H, Pogue, J, Sheridan, P, Dagenais, G, Diaz, R, Avezum, A, Lanas, F, Probstfield, J, Fodor, G, Holman, R
Format:	Journal article
Sprog:	English
Udgivet:	2006

Lignende værker

Incidence of diabetes following ramipril or rosiglitazone withdrawal
af: Holman, R, et al.
Udgivet: (2011)

Incidence of diabetes following ramipril or rosiglitazone withdrawal.
af: Investigators, D
Udgivet: (2011)

Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial.
af: Punthakee, Z, et al.
Udgivet: (2012)

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
af: Gerstein, H, et al.
Udgivet: (2006)

Trial update: the Diabetes REduction Approaches with ramipril and rosiglitazone Medications (DREAM) trial
af: G. Gulli
Udgivet: (2013-05-01)

Ramipril induced pemphigoid vulgaris
af: Mirza MA, et al.
Udgivet: (2018-09-01)

Ramipril therapy in acute myocardial infarction
af: V. A. Lusov, et al.
Udgivet: (2008-10-01)

Ramipril poisoning rescued by naloxone and terlipressin
af: Samanta Samanta, et al.
Udgivet: (2014-01-01)

The Degradation Product of Ramipril Is Potentially Carcinogenic, Genotoxic and Mutagenic
af: Katarzyna Regulska, et al.
Udgivet: (2023-02-01)

Effect of ramipril on renal function in patients with intermittent claudication
af: Simon D Hobbs, et al.
Udgivet: (2008-04-01)

A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes
af: Hertzel C. Gerstein, et al.
Udgivet: (2022-08-01)

V fokuse vnimaniya - ingibitoryangiotenzinprevrashchayushchegofermenta: ramipril priarterial'noy gipertonii
af: I E Chazova, et al.
Udgivet: (2011-09-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
af: I. V. Szirov, et al.
Udgivet: (2015-12-01)

FIXED COMBINATION OF RAMIPRIL AND HYDROCHLOROTHIAZIDE: TO WHOM AND WHAT FOR?
af: S. V. Nedogoda
Udgivet: (2016-09-01)

Development of Methods of Quality Control of the Tablets «Ramipril»
af: Kateryna Typlynska, et al.
Udgivet: (2023-04-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
af: I. V. Szirov, et al.
Udgivet: (2015-12-01)

Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: Results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial
Udgivet: (2008)

The place of ramipril in modern guidelines for the management of patients with cardiovascular diseases
af: E. E. Averin, et al.
Udgivet: (2019-01-01)

Effect of Valsartan on the Incidence of Diabetes REPLY
af: Holman, R, et al.
Udgivet: (2010)

RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS
af: S. R. Willoughby, et al.
Udgivet: (2015-12-01)

RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS
af: S. R. Willoughby, et al.
Udgivet: (2015-12-01)

Comparison of the efficacy, safety and tolerability of ramipril with amlodipine in treatment of mild to moderate hypertension in Nigerians
af: B J C Onwubere, et al.
Udgivet: (2007-01-01)

MARRIAGE: A Randomized Trial of Moxonidine Ramipril or in Combination With Ramipril in Overweight Patients With Hypertension and Impaired Fasting Glucose or Diabetes Mellitus. Impact on Blood Pressure, Heart Rate and Metabolic Parameters
af: Paul Valensi MD, et al.
Udgivet: (2024-06-01)

Three-dimensional printing of ramipril tablets by fused deposition modeling
af: O. A. Terenteva, et al.
Udgivet: (2021-12-01)

Comparative effectiveness of fixed combinations of various ramipril and hydrochlorothiazide doses
af: I. E. Chazova, et al.
Udgivet: (2010-08-01)

Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored.
af: McMurray, J, et al.
Udgivet: (2014)

THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
af: V. I. Podzolkov, et al.
Udgivet: (2015-09-01)

THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
af: V. I. Podzolkov, et al.
Udgivet: (2015-09-01)

Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL Study (Diabete, Ipertensione, Albuminuria, Lercanidipina)
af: M. Dalla Vestra, et al.
Udgivet: (1970-01-01)

RAMIPRIL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE
af: A. I. Chesnikova, et al.
Udgivet: (2016-01-01)

Solid-State Stability Profiling of Ramipril to Optimize Its Quality Efficiency and Safety
af: Katarzyna Regulska, et al.
Udgivet: (2021-10-01)

ESTIMATION OF NEPHROPROTECTIVE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME RAMIPRIL IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS
af: M.A. Dolinnayä, et al.
Udgivet: (2017-03-01)

CHANGES IN CLINICAL MANIFESTATION OF CONGESTIVE HEART FAILURE AT THE BACKGROUND OF REGULAR RAMIPRIL INTAKE
af: A. G. Kuzmin, et al.
Udgivet: (2014-08-01)

Efficiency (advantages) of ramipril in arterial hypertension and diabetes mellitus from the point of view of evidence-based medicine
af: M. V. Leonova
Udgivet: (2020-05-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
af: D. A. Napalkov, et al.
Udgivet: (2016-01-01)

DISSOLUTION PROFILE STUDIES FOR RAMIPRIL AND LERCANIDIPINE FIXED-DOSE COMBINATION
af: A. A. Shadrin, et al.
Udgivet: (2019-01-01)

The effects of sacubitril/valsartan and ramipril on the male fertility in hypertensive rats
af: Duygun Altıntaş Aykan, et al.
Udgivet: (2020-10-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
af: D. A. Napalkov, et al.
Udgivet: (2016-01-01)

Modern antihypertensive therapy: the effectiveness of a unique Russian fixed-dose combination of ramipril and indapamide
af: A. O. Konradi, et al.
Udgivet: (2020-04-01)

Development and validation of a stability indicating UPLC-DAD method coupled with MS-TQD for ramipril and thymoquinone in bioactive SNEDDS with in silico toxicity analysis of ramipril degradation products
af: Elzayat Ehab M., et al.
Udgivet: (2024-08-01)